Primary biliary cholangitis is a medical condition with active clinical research programs worldwide.

17 total trials for this combination

Showing top 10 of 17 trials

Trials

NCT ID	Title	Status	Phase
NCT06447168	A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment	RECRUITING	—
NCT03602560	ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)	COMPLETED	PHASE3
NCT06247735	Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.	ACTIVE_NOT_RECRUITING	PHASE2
NCT06060665	Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)	ACTIVE_NOT_RECRUITING	PHASE3
NCT04620733	RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)	COMPLETED	PHASE3
NCT05050136	A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis	RECRUITING	PHASE2
NCT05133336	Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis	COMPLETED	—
NCT06051617	Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis	RECRUITING	—
NCT03394924	A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis	COMPLETED	PHASE2
NCT05014672	A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness	COMPLETED	PHASE2

Related Pages

All Primary biliary cholangitis trials All trials in Miami, United States